Federal Drug Administration FDA

Congress: Drop Sec. 716 — FDA Exemption — From NDAA

The 2018 National Defense Authorization Act contains billions of dollars and much policy concerning medical research and, of course, matters relating to nuclear, biological and chemical warfare. We don’t cover most of those medical issues except when they relate to NBC issues or raise basic military policy considerations. This is one of those cases. In […]